<?xml version="1.0" encoding="UTF-8"?>
<html lang="en" dir="ltr" xmlns="http://www.w3.org/1999/xhtml">
 <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#"> 
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> 
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3, minimum-scale=1, user-scalable=yes"/>
  <meta name="type" content="article"/>
  <meta name="category" content="article"/>
  <meta name="HW.identifier" content="/biorxiv/early/2020/03/31/2020.03.29.014183.atom"/>
  <meta name="HW.pisa" content="biorxiv;2020.03.29.014183v1"/>
  <meta name="DC.Format" content="text/html"/>
  <meta name="DC.Language" content="en"/>
  <meta name="DC.Title" content="HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoV"/>
  <meta name="DC.Identifier" content="10.1101/2020.03.29.014183"/>
  <meta name="DC.Date" content="2020-03-31"/>
  <meta name="DC.Publisher" content="Cold Spring Harbor Laboratory"/>
  <meta name="DC.Rights" content="© 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission."/>
  <meta name="DC.AccessRights" content="restricted"/>
  <meta name="DC.Description" content="The beginning of 2020 brought us information about the novel coronavirus emerging in China. Rapid research resulted in the characterization of the pathogen, which appeared to be a member of the SARS-like cluster, commonly seen in bats. Despite the global and local efforts, the virus escaped the healthcare measures and rapidly spread in China and later globally, officially causing a pandemic and global crisis in March 2020. At present, different scenarios are being written to contain the virus, but the development of novel anticoronavirals for all highly pathogenic coronaviruses remains the major challenge. Here, we describe the antiviral activity of previously developed by us HTCC compound (N-(2-hydroxypropyl)-3-trimethylammonium chitosan chloride), which may be used as potential inhibitor of currently circulating highly pathogenic coronaviruses – SARS-CoV-2 and MERS-CoV."/>
  <meta name="DC.Contributor" content="Aleksandra Milewska"/>
  <meta name="DC.Contributor" content="Ying Chi"/>
  <meta name="DC.Contributor" content="Artur Szczepanski"/>
  <meta name="DC.Contributor" content="Emilia Barreto-Duran"/>
  <meta name="DC.Contributor" content="Kevin Liu"/>
  <meta name="DC.Contributor" content="Dan Liu"/>
  <meta name="DC.Contributor" content="Xiling Guo"/>
  <meta name="DC.Contributor" content="Yiyue Ge"/>
  <meta name="DC.Contributor" content="Jingxin Li"/>
  <meta name="DC.Contributor" content="Lunbiao Cui"/>
  <meta name="DC.Contributor" content="Marek Ochman"/>
  <meta name="DC.Contributor" content="Maciej Urlik"/>
  <meta name="DC.Contributor" content="Sylwia Rodziewicz-Motowidlo"/>
  <meta name="DC.Contributor" content="Fengcai Zhu"/>
  <meta name="DC.Contributor" content="Krzysztof Szczubialka"/>
  <meta name="DC.Contributor" content="Maria Nowakowska"/>
  <meta name="DC.Contributor" content="Krzysztof Pyrc"/>
  <meta name="article:published_time" content="2020-03-31"/>
  <meta name="article:section" content="New Results"/>
  <meta name="citation_title" content="HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoV"/>
  <meta name="citation_abstract" lang="en" content="&lt;;p&gt;;The beginning of 2020 brought us information about the novel coronavirus emerging in China. Rapid research resulted in the characterization of the pathogen, which appeared to be a member of the SARS-like cluster, commonly seen in bats. Despite the global and local efforts, the virus escaped the healthcare measures and rapidly spread in China and later globally, officially causing a pandemic and global crisis in March 2020. At present, different scenarios are being written to contain the virus, but the development of novel anticoronavirals for all highly pathogenic coronaviruses remains the major challenge. Here, we describe the antiviral activity of previously developed by us HTCC compound (N-(2-hydroxypropyl)-3-trimethylammonium chitosan chloride), which may be used as potential inhibitor of currently circulating highly pathogenic coronaviruses - SARS-CoV-2 and MERS-CoV.&lt;;/p&gt;;"/>
  <meta name="citation_journal_title" content="bioRxiv"/>
  <meta name="citation_publisher" content="Cold Spring Harbor Laboratory"/>
  <meta name="citation_publication_date" content="2020/01/01"/>
  <meta name="citation_mjid" content="biorxiv;2020.03.29.014183v1"/>
  <meta name="citation_id" content="2020.03.29.014183v1"/>
  <meta name="citation_public_url" content="https://www.biorxiv.org/content/10.1101/2020.03.29.014183v1"/>
  <meta name="citation_abstract_html_url" content="https://www.biorxiv.org/content/10.1101/2020.03.29.014183v1.abstract"/>
  <meta name="citation_full_html_url" content="https://www.biorxiv.org/content/10.1101/2020.03.29.014183v1.full"/>
  <meta name="citation_pdf_url" content="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183.full.pdf"/>
  <meta name="citation_doi" content="10.1101/2020.03.29.014183"/>
  <meta name="citation_num_pages" content="21"/>
  <meta name="citation_article_type" content="Article"/>
  <meta name="citation_section" content="New Results"/>
  <meta name="citation_firstpage" content="2020.03.29.014183"/>
  <meta name="citation_author" content="Aleksandra Milewska"/>
  <meta name="citation_author_institution" content="Virogenetics Laboratory of Virology, Malopolska Centre of Biotechnology, Jagiellonian University"/>
  <meta name="citation_author_institution" content="Microbiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University"/>
  <meta name="citation_author_email" content="k.a.pyrc@uj.edu.pl"/>
  <meta name="citation_author_email" content="maria.nowakowska@uj.edu.pl"/>
  <meta name="citation_author_email" content="krzysztof.szczubialka@uj.edu.pl"/>
  <meta name="citation_author_email" content="jszfc@vip.sina.com"/>
  <meta name="citation_author_email" content="aleksandra.milewska@uj.edu.pl"/>
  <meta name="citation_author_orcid" content="http://orcid.org/0000-0003-0895-8697"/>
  <meta name="citation_author" content="Ying Chi"/>
  <meta name="citation_author_institution" content="NHC Key Lab of Enteric Pathogenic Microbiology, Jiangsu Provincial Centre for Disease Control &amp;; Prevention"/>
  <meta name="citation_author" content="Artur Szczepanski"/>
  <meta name="citation_author_institution" content="Virogenetics Laboratory of Virology, Malopolska Centre of Biotechnology, Jagiellonian University"/>
  <meta name="citation_author_institution" content="Microbiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University"/>
  <meta name="citation_author" content="Emilia Barreto-Duran"/>
  <meta name="citation_author_institution" content="Virogenetics Laboratory of Virology, Malopolska Centre of Biotechnology, Jagiellonian University"/>
  <meta name="citation_author" content="Kevin Liu"/>
  <meta name="citation_author_institution" content="Nanjing Techboon Institute of Clinical Medicine. #1003, Tower B of Yangtze Sci. &amp;; Tech. Innovation Centre"/>
  <meta name="citation_author" content="Dan Liu"/>
  <meta name="citation_author_institution" content="Nanjing Techboon Institute of Clinical Medicine. #1003, Tower B of Yangtze Sci. &amp;; Tech. Innovation Centre"/>
  <meta name="citation_author" content="Xiling Guo"/>
  <meta name="citation_author_institution" content="NHC Key Lab of Enteric Pathogenic Microbiology, Jiangsu Provincial Centre for Disease Control &amp;; Prevention"/>
  <meta name="citation_author" content="Yiyue Ge"/>
  <meta name="citation_author_institution" content="NHC Key Lab of Enteric Pathogenic Microbiology, Jiangsu Provincial Centre for Disease Control &amp;; Prevention"/>
  <meta name="citation_author" content="Jingxin Li"/>
  <meta name="citation_author_institution" content="NHC Key Lab of Enteric Pathogenic Microbiology, Jiangsu Provincial Centre for Disease Control &amp;; Prevention"/>
  <meta name="citation_author" content="Lunbiao Cui"/>
  <meta name="citation_author_institution" content="NHC Key Lab of Enteric Pathogenic Microbiology, Jiangsu Provincial Centre for Disease Control &amp;; Prevention"/>
  <meta name="citation_author" content="Marek Ochman"/>
  <meta name="citation_author_institution" content="Department of Cardiac, Vascular and Endovascular Surgery and Transplantology, Medical University of Silesia in Katowice, Silesian Centre for Heart Diseases"/>
  <meta name="citation_author" content="Maciej Urlik"/>
  <meta name="citation_author_institution" content="Department of Cardiac, Vascular and Endovascular Surgery and Transplantology, Medical University of Silesia in Katowice, Silesian Centre for Heart Diseases"/>
  <meta name="citation_author" content="Sylwia Rodziewicz-Motowidlo"/>
  <meta name="citation_author_institution" content="Department of Biomedical Chemistry, Faculty of Chemistry, University of Gdansk"/>
  <meta name="citation_author" content="Fengcai Zhu"/>
  <meta name="citation_author_institution" content="NHC Key Lab of Enteric Pathogenic Microbiology, Jiangsu Provincial Centre for Disease Control &amp;; Prevention"/>
  <meta name="citation_author_institution" content="Centre for Global Health, Nanjing Medical University"/>
  <meta name="citation_author_email" content="k.a.pyrc@uj.edu.pl"/>
  <meta name="citation_author_email" content="maria.nowakowska@uj.edu.pl"/>
  <meta name="citation_author_email" content="krzysztof.szczubialka@uj.edu.pl"/>
  <meta name="citation_author_email" content="jszfc@vip.sina.com"/>
  <meta name="citation_author_email" content="aleksandra.milewska@uj.edu.pl"/>
  <meta name="citation_author" content="Krzysztof Szczubialka"/>
  <meta name="citation_author_institution" content="Department of Physical Chemistry, Faculty of Chemistry, Jagiellonian University"/>
  <meta name="citation_author_email" content="k.a.pyrc@uj.edu.pl"/>
  <meta name="citation_author_email" content="maria.nowakowska@uj.edu.pl"/>
  <meta name="citation_author_email" content="krzysztof.szczubialka@uj.edu.pl"/>
  <meta name="citation_author_email" content="jszfc@vip.sina.com"/>
  <meta name="citation_author_email" content="aleksandra.milewska@uj.edu.pl"/>
  <meta name="citation_author" content="Maria Nowakowska"/>
  <meta name="citation_author_institution" content="Department of Physical Chemistry, Faculty of Chemistry, Jagiellonian University"/>
  <meta name="citation_author_email" content="k.a.pyrc@uj.edu.pl"/>
  <meta name="citation_author_email" content="maria.nowakowska@uj.edu.pl"/>
  <meta name="citation_author_email" content="krzysztof.szczubialka@uj.edu.pl"/>
  <meta name="citation_author_email" content="jszfc@vip.sina.com"/>
  <meta name="citation_author_email" content="aleksandra.milewska@uj.edu.pl"/>
  <meta name="citation_author" content="Krzysztof Pyrc"/>
  <meta name="citation_author_institution" content="Virogenetics Laboratory of Virology, Malopolska Centre of Biotechnology, Jagiellonian University"/>
  <meta name="citation_author_email" content="k.a.pyrc@uj.edu.pl"/>
  <meta name="citation_author_email" content="maria.nowakowska@uj.edu.pl"/>
  <meta name="citation_author_email" content="krzysztof.szczubialka@uj.edu.pl"/>
  <meta name="citation_author_email" content="jszfc@vip.sina.com"/>
  <meta name="citation_author_email" content="aleksandra.milewska@uj.edu.pl"/>
  <meta name="citation_author_orcid" content="http://orcid.org/0000-0002-3867-7688"/>
  <meta name="citation_reference" content="Fields, B. N., Knipe, D. M. &amp;; Howley, P. M. Fields virology. 6th edn, (Wolters Kluwer Health/Lippincott Williams &amp;; Wilkins, 2013)."/>
  <meta name="citation_reference" content="Peiris, J. S., Yuen, K. Y., Osterhaus, A. D. &amp;; Stöhr, K. The severe acute respiratory syndrome. N Engl J Med 349, 2431–2441, doi:10.1056/NEJMra032498 (2003)."/>
  <meta name="citation_reference" content="de Groot, R. J. et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol 87, 7790–7792, doi:10.1128/JVI.01244-13 (2013)."/>
  <meta name="citation_reference" content="Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. &amp;; Fouchier, R. A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367, 1814–1820, doi:10.1056/NEJMoa1211721 (2012)."/>
  <meta name="citation_reference" content="van der Hoek, L. et al. Identification of a new human coronavirus. Nat Med 10, 368–373, doi:10.1038/nm1024 (2004)."/>
  <meta name="citation_reference" content="van der Hoek, L. et al. Croup is associated with the novel coronavirus NL63. PLoS Med 2, e240, doi:10.1371/journal.pmed.0020240 (2005)."/>
  <meta name="citation_reference" content="Zhu, N. et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 382, 727–733, doi:10.1056/NEJMoa2001017 (2020)."/>
  <meta name="citation_reference" content="&lt;;https://www.who.int/emergencies/diseases/novel-coronavirus-2019&gt;; ("/>
  <meta name="citation_reference" content="Andersen, K. G., Rambaut, A. &amp;; Lipkin, W. I. The proximal origin of SARS-CoV-2. Nature Medicine, doi:https://doi.org/10.1038/s41591-020-0820-9 (2020)."/>
  <meta name="citation_reference" content="Corman, V. M. et al. Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat. J Virol 88, 11297–11303, doi:10.1128/JVI.01498-14 (2014)."/>
  <meta name="citation_reference" content="Zhang, Z., Shen, L. &amp;; Gu, X. Evolutionary Dynamics of MERS-CoV: Potential Recombination, Positive Selection and Transmission. Sci Rep 6, 25049, doi:10.1038/srep25049 (2016)."/>
  <meta name="citation_reference" content="Lu, G. et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 500, 227–231, doi:10.1038/nature12328 (2013)."/>
  <meta name="citation_reference" content="Raj, V. S. et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495, 251–254, doi:10.1038/nature12005 (2013)."/>
  <meta name="citation_reference" content="Mackay, I. M. &amp;; Arden, K. E. MERS coronavirus: diagnostics, epidemiology and transmission. Virol J 12, 222, doi:10.1186/s12985-015-0439-5 (2015)."/>
  <meta name="citation_reference" content="Milne-Price, S., Miazgowicz, K. L. &amp;; Munster, V. J. The emergence of the Middle East respiratory syndrome coronavirus. Pathog Dis 71, 121–136, doi:10.1111/2049-632X.12166 (2014)."/>
  <meta name="citation_reference" content="Chan, R. W. et al. Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study. Lancet Respir Med 2, 813–822, doi:10.1016/S2213-2600(14)70158-4 (2014)."/>
  <meta name="citation_reference" content="Agostini, M. L. et al. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. mBio 9, doi:10.1128/mBio.00221-18 (2018)."/>
  <meta name="citation_reference" content="Agnihothram, S. et al. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant. MBio 5, e00047–00014, doi:10.1128/mBio.00047-14 (2014)."/>
  <meta name="citation_reference" content="Ratia, K. et al. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proc Natl Acad Sci U S A 105, 16119–16124, doi:10.1073/pnas.0805240105 (2008)."/>
  <meta name="citation_reference" content="Barnard, D. L. et al. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin. Antiviral Res 71, 53–63, doi:10.1016/j.antiviral.2006.03.001 (2006)."/>
  <meta name="citation_reference" content="Cheng, V. C., Lau, S. K., Woo, P. C. &amp;; Yuen, K. Y. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 20, 660–694, doi:10.1128/CMR.00023-07 (2007)."/>
  <meta name="citation_reference" content="Milewska, A. et al. HTCC: Broad Range Inhibitor of Coronavirus Entry. PLoS One 11, e0156552, doi:10.1371/journal.pone.0156552 (2016)."/>
  <meta name="citation_reference" content="Milewska, A. et al. Novel polymeric inhibitors of HCoV-NL63. Antiviral Res 97, 112–121, doi:10.1016/j.antiviral.2012.11.006 (2013)."/>
  <meta name="citation_reference" content="Kamil, K., Aleksandra, M., Maria, N., Krzysztof, P. &amp;; Krzysztof, S. THE USE OF CHITOSAN POLYMER IN THE TREATMENT AND PREVENTION OF INFECTIONS CAUSED BY CORONAVIRUSES."/>
  <meta name="citation_reference" content="Yang, T. T. et al. Cyclosporine A/porous quaternized chitosan microspheres as a novel pulmonary drug delivery system. Artif Cells Nanomed Biotechnol 46, 552–564, doi:10.1080/21691401.2018.1463231 (2018)."/>
  <meta name="citation_reference" content="A, M. et al."/>
  <meta name="citation_reference" content="Kühtreiber, W. M., P., L. R., Chick, W. L. &amp;; View ORCID Profil Anna Kula-Pacurar, J. W., Agnieszka Suder, Artur Szczepanski, Agnieszka Dabrowska, Katarzyna Owczarek, Marek Ochman, Tomasz Stacel View ORCID Profile. Cell Encapsulation Technology and Therapeutics. (1999)."/>
  <meta name="citation_reference" content="Ciejka, J., Wolski, K., Nowakowska, M., Pyrc, K. &amp;; Szczubiałka, K. Biopolymeric nano/microspheres for selective and reversible adsorption of coronaviruses. Mater Sci Eng C Mater Biol Appl 76, 735–742, doi:10.1016/j.msec.2017.03.047 (2017)."/>
  <meta name="citation_reference" content="Milewska, A. et al. Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells. J Virol 88, 13221–13230, doi:10.1128/JVI.02078-14 (2014)."/>
  <meta name="twitter:title" content="HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoV"/>
  <meta name="twitter:site" content="@biorxivpreprint"/>
  <meta name="twitter:card" content="summary"/>
  <meta name="twitter:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png"/>
  <meta name="twitter:description" content="The beginning of 2020 brought us information about the novel coronavirus emerging in China. Rapid research resulted in the characterization of the pathogen, which appeared to be a member of the SARS-like cluster, commonly seen in bats. Despite the global and local efforts, the virus escaped the healthcare measures and rapidly spread in China and later globally, officially causing a pandemic and global crisis in March 2020. At present, different scenarios are being written to contain the virus, but the development of novel anticoronavirals for all highly pathogenic coronaviruses remains the major challenge. Here, we describe the antiviral activity of previously developed by us HTCC compound (N-(2-hydroxypropyl)-3-trimethylammonium chitosan chloride), which may be used as potential inhibitor of currently circulating highly pathogenic coronaviruses – SARS-CoV-2 and MERS-CoV."/>
  <meta name="og-title" property="og:title" content="HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoV"/>
  <meta name="og-url" property="og:url" content="https://www.biorxiv.org/content/10.1101/2020.03.29.014183v1"/>
  <meta name="og-site-name" property="og:site_name" content="bioRxiv"/>
  <meta name="og-description" property="og:description" content="The beginning of 2020 brought us information about the novel coronavirus emerging in China. Rapid research resulted in the characterization of the pathogen, which appeared to be a member of the SARS-like cluster, commonly seen in bats. Despite the global and local efforts, the virus escaped the healthcare measures and rapidly spread in China and later globally, officially causing a pandemic and global crisis in March 2020. At present, different scenarios are being written to contain the virus, but the development of novel anticoronavirals for all highly pathogenic coronaviruses remains the major challenge. Here, we describe the antiviral activity of previously developed by us HTCC compound (N-(2-hydroxypropyl)-3-trimethylammonium chitosan chloride), which may be used as potential inhibitor of currently circulating highly pathogenic coronaviruses – SARS-CoV-2 and MERS-CoV."/>
  <meta name="og-type" property="og:type" content="article"/>
  <meta name="og-image" property="og:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png"/>
  <meta name="citation_date" content="2020-03-31"/> 
  <meta name="description" content="bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution"/>
  <meta name="generator" content="Drupal 7 (http://drupal.org)"/> 
  <title>HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoV | bioRxiv</title> 
 </head>
 <body class="html not-front not-logged-in page-node page-node- page-node-1219040 node-type-highwire-article context-content hw-default-jcode-biorxiv hw-article-type-article hw-article-category-new-results"> 
  <div class="article fulltext-view ">
   <span class="highwire-journal-article-marker-start"/>
   <div class="section abstract" id="abstract-1">
    <h2 class="">ABSTRACT</h2>
    <p id="p-2">The beginning of 2020 brought us information about the novel coronavirus emerging in China. Rapid research resulted in the characterization of the pathogen, which appeared to be a member of the SARS-like cluster, commonly seen in bats. Despite the global and local efforts, the virus escaped the healthcare measures and rapidly spread in China and later globally, officially causing a pandemic and global crisis in March 2020. At present, different scenarios are being written to contain the virus, but the development of novel anticoronavirals for all highly pathogenic coronaviruses remains the major challenge. Here, we describe the antiviral activity of previously developed by us HTCC compound (N-(2-hydroxypropyl)-3-trimethylammonium chitosan chloride), which may be used as potential inhibitor of currently circulating highly pathogenic coronaviruses – SARS-CoV-2 and MERS-CoV.</p>
   </div>
   <div class="section" id="sec-1">
    <h2 class="">INTRODUCTION</h2>
    <p id="p-3">Coronaviruses mainly cause respiratory and enteric diseases in humans, other mammals, and birds. However, some species can cause more severe conditions such as hepatitis, peritonitis, or neurological disease. Seven coronaviruses infect humans, four of which (human coronavirus [HCoV]-229E, HCoV-NL63, HCoV-OC43, and HCoV-HKU1) cause relatively mild upper and lower respiratory tract disease. Other three zoonotic coronaviruses - the severe acute respiratory syndrome coronaviruses (SARS-CoV and SARS-CoV-2) and the Middle East respiratory syndrome coronavirus (MERS-CoV) are associated with severe, life-threatening respiratory infections and multiorgan failure 
     <sup>
      <a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>–
      <a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>
     </sup>.
    </p>
    <p id="p-4">SARS-CoV-2 emerged in the Hubei province of China by the end of 2019 and caused an epidemic that was partially contained in China by March 2020. However, the virus rapidly spread globally and caused the pandemic 
     <sup>
      <a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>
     </sup>. SARS-CoV-2 is a betacoronavirus and belongs to a large cluster of SARS-like viruses in bats, classified in 
     <em>Sarbecovirus</em> subgenus. While bats are considered to be the original reservoir, it is believed that there is an intermediate host, and pangolins were suggested as such 
     <sup>
      <a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a>
     </sup>. The virus is associated with a respiratory illness that, in a proportion of cases, is severe. The mortality rate varies between locations, but at present, is estimated to reach 3-4% globally. The virus infects primarily ciliated cells and type II pneumocytes in human airways, hijacking the angiotensin-converting enzyme 2 (ACE2) to enter the cell, similarly as SARS-CoV and HCoV-NL63.
    </p>
    <p id="p-5">MERS-CoV is related to SARS-CoV-2, but together with some bat viruses forms a separate 
     <em>Merbecovirus</em> subgenus. Bats are believed to serve as an original reservoir also in this case 
     <sup>
      <a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>
     </sup>, but camels were identified as the intermediate host 
     <sup>
      <a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a>
     </sup>. The virus never fully crossed the species border, as the human-to-human transmission is limited, and almost all the cases are associated with animal-to-human transmission. The entry receptor for MERS-CoV is the dipeptidyl peptidase 4 (DPP4) 
     <sup>
      <a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a>,
      <a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a>
     </sup>. In humans, MERS-CoV causes a respiratory illness with severity varying from asymptomatic to potentially fatal acute respiratory distress 
     <sup>
      <a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a>–
      <a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a>
     </sup>. To date, MERS-CoV infection was confirmed in 27 countries, with over 2,000 cases and a mortality rate of ~35%.
    </p>
    <p id="p-6">Currently, there are no vaccines or drugs with proven efficacy to treat coronavirus infection, and treatment is limited to supportive care. However, a range of therapeutics have been experimentally used in clinic to treat SARS-CoV-2 and MERS-CoV-infected patients, and their use is based on the knowledge obtained in previous years. The most promising drug candidates include broad-spectrum polymerase inhibitors (remdesivir) 
     <sup>
      <a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a>
     </sup> and some re-purposed drugs (e.g., HIV-1 protease inhibitors). However, until today none of these has proven effective in randomized controlled trials. On the other hand, the antiviral potential of several small molecules have been demonstrated in cell lines 
     <em>in vitro</em>, but their effectiveness 
     <em>in vivo</em> have not been confirmed 
     <sup>
      <a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a>,
      <a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a>
     </sup>. For the ones that reached animal models, some promising drug candidates have been shown to exacerbate the disease (ribavirin, mycophenolic acid) 
     <sup>
      <a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a>
     </sup>.
    </p>
    <p id="p-7">Drug development for SARS-CoV-2 and MERS-CoV is of great importance, but considering the diversity of coronaviruses and the proven propensity to cross the species barrier, the SARS-CoV-2 epidemic is probably not the last one. Warnings about the possibility of another SARS-CoV epidemic have appeared in the scientific literature for a long time 
     <sup>
      <a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a>
     </sup>. Consequently, broad-spectrum antivirals are essential in long-term perspective.
    </p>
    <p id="p-8">Previously, we have demonstrated an antiviral potential of the HTCC polymer (N-(2-hydroxypropyl)-3-trimethylammonium chitosan chloride), which efficiently hampered infection of all low pathogenic human coronaviruses 
     <em>in vitro</em> and 
     <em>ex vivo</em>
     <sup>
      <a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a>
     </sup> and several animal coronaviruses (
     <em>unpublished data</em>). Furthermore, using several functional and structural assays, we dissected the mechanism of the HTCC antiviral activity. We showed that the polymer interacts with the coronaviral Spike (S) protein and blocks its interaction with the cellular receptor 
     <sup>
      <a id="xref-ref-22-2" class="xref-bibr" href="#ref-22">22</a>–
      <a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a>
     </sup>. Here, we analyzed the HTCC activity against SARS-CoV-2 and MERS-CoV 
     <em>in vitro</em> using permissive cell lines and 
     <em>ex vivo</em>, using a model of human airway epithelium (HAE). The study showed that the replication of both viruses was efficiently hampered. Overall, our data show that HTCC polymers are potent broad-spectrum anticoronavirals and may be very promising drug candidates for SARS-CoV-2 and MERS-CoV.
    </p>
   </div>
   <div class="section" id="sec-2">
    <h2 class="">RESULTS AND DISCUSSION</h2>
    <div id="sec-3" class="subsection">
     <h3>HTCCs hamper MERS-CoV and SARS-CoV-2 replication in cell lines</h3>
     <p id="p-9">Previously, we showed that HTCC with different degrees of substitution (DSs) is a potent inhibitor of all four low pathogenic HCoVs 
      <sup>
       <a id="xref-ref-22-3" class="xref-bibr" href="#ref-22">22</a>
      </sup>. DSs are expressed as the fraction of NH
      <sub>2</sub> groups of gluocosamine units in chitosan substituted with glycidyltrimethylammonium chloride (GTMAC). The DS of the studied HTCC polymers varied between 57% and 77%; thus, the polymers were named HTCC-57, HTCC-62, HTCC-63, HTCC-65, and HTCC-77. The synthesis and characterization of polymers are described elsewhere 
      <sup>
       <a id="xref-ref-22-4" class="xref-bibr" href="#ref-22">22</a>,
       <a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">23</a>
      </sup>. The analysis showed that HTCC-63 demonstrated the most significant inhibitory effect on HCoV-NL63, HCoV-OC43, and HCoV-HKU1. On the other hand, HTCC-62 and HTCC-77 proved to be effective inhibitors of HCoV-229E infection. Further, HTCC-65 effectively inhibited the replication of HCoV-NL63 and HCoV-OC43, while HTCC-62 showed a potent antiviral effect on HCoV-HKU1 infection.
     </p>
     <p id="p-10">The study on the MERS-CoV using the Vero cells revealed that all HTCC variants inhibit virus replication to a similar extent (~100-1000-time decrease in viral yields), at non-toxic concentration (
      <strong>
       <a id="xref-fig-1-1" class="xref-fig" href="#F1">Figure 1A, C</a>
      </strong>). The inhibition of the SARS-CoV-2 infection in Vero E6 cells was even more pronounced, and all HTCC variants inhibited virus replication by ~10,000 times at non-toxic concentration (
      <strong>
       <a id="xref-fig-1-2" class="xref-fig" href="#F1">Figure 1B, C</a>
      </strong>). In this case, the HTCC-63 was arbitrarily selected for further studies on MERS-CoV, while HTCC-77 was selected for SARS-CoV-2.
     </p>
     <div id="F1" class="fig pos-float type-figure odd">
      <div class="highwire-figure">
       <div class="fig-inline-img-wrapper">
        <div class="fig-inline-img">
         <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F1.large.jpg?width=800&amp;;height=600&amp;;carousel=1" title="In vitro inhibition of MERS-CoV and SARS-CoV-2 by HTCC at non toxic concentration. Vero cells were infected with MERS-CoV (A), and Vero E6 cells were infected with SARS-CoV-2 (B). Briefly, cultures were inoculated with a given virus in the presence of HTCC (100 [[#x3BC]]g/ml) or control PBS. Replication of viruses was evaluated at 48 h post-inoculation using RT-qPCR. The data are presented as Log Removal Value (LRV) compared to the untreated sample. The assay was performed in triplicate, and average values with standard errors are shown. (C) Cytotoxicity of HTCCs with DS ranging from 57% to 77% in vitro at 100 [[#x3BC]]g/ml. Cell viability was assessed with XTT assay. Data on the y-axis represent the percentage of values obtained for the untreated reference samples. All assays were performed in triplicate, and average values with standard errors are presented. The differences in cytotoxicity of HTCCs were not statistically significant." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1117103470" data-figure-caption="&lt;;div class=&quot;;highwire-markup&quot;;&gt;;&lt;;div xmlns=&quot;;http://www.w3.org/1999/xhtml&quot;;&gt;;&lt;;span class=&quot;;caption-title&quot;;&gt;;&lt;;em&gt;;In vitro&lt;;/em&gt;; inhibition of MERS-CoV and SARS-CoV-2 by HTCC at non toxic concentration.&lt;;/span&gt;; Vero cells were infected with MERS-CoV (&lt;;strong&gt;;A&lt;;/strong&gt;;), and Vero E6 cells were infected with SARS-CoV-2 (&lt;;strong&gt;;B&lt;;/strong&gt;;). Briefly, cultures were inoculated with a given virus in the presence of HTCC (100 [[#x3BC]]g/ml) or control PBS. Replication of viruses was evaluated at 48 h post-inoculation using RT-qPCR. The data are presented as Log Removal Value (LRV) compared to the untreated sample. The assay was performed in triplicate, and average values with standard errors are shown. (&lt;;strong&gt;;C&lt;;/strong&gt;;) Cytotoxicity of HTCCs with DS ranging from 57% to 77% &lt;;em&gt;;in vitro&lt;;/em&gt;; at 100 [[#x3BC]]g/ml. Cell viability was assessed with XTT assay. Data on the y-axis represent the percentage of values obtained for the untreated reference samples. All assays were performed in triplicate, and average values with standard errors are presented. The differences in cytotoxicity of HTCCs were not statistically significant.&lt;;/div&gt;;&lt;;/div&gt;;" data-icon-position="" data-hide-link-title="0">
          <span class="hw-responsive-img">
           <img class="highwire-fragment fragment-image lazyload" alt="Figure 1." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F1.medium.gif" width="207" height="440"/>
           <noscript>
            <img class="highwire-fragment fragment-image" alt="Figure 1." src="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F1.medium.gif" width="207" height="440"/>
           </noscript>
          </span>
         </a>
        </div>
       </div>
       <ul class="highwire-figure-links inline">
        <li class="download-fig first">
         <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F1.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 1." data-icon-position="" data-hide-link-title="0">Download figure</a>
        </li>
        <li class="new-tab last">
         <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F1.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a>
        </li>
       </ul>
      </div>
      <div class="fig-caption">
       <span class="fig-label">Figure 1.</span>
       <span class="caption-title">
        <em>In vitro</em> inhibition of MERS-CoV and SARS-CoV-2 by HTCC at non toxic concentration.
       </span>
       <p id="p-11" class="first-child">Vero cells were infected with MERS-CoV (
        <strong>A</strong>), and Vero E6 cells were infected with SARS-CoV-2 (
        <strong>B</strong>). Briefly, cultures were inoculated with a given virus in the presence of HTCC (100 μg/ml) or control PBS. Replication of viruses was evaluated at 48 h post-inoculation using RT-qPCR. The data are presented as Log Removal Value (LRV) compared to the untreated sample. The assay was performed in triplicate, and average values with standard errors are shown. (
        <strong>C</strong>) Cytotoxicity of HTCCs with DS ranging from 57% to 77% 
        <em>in vitro</em> at 100 μg/ml. Cell viability was assessed with XTT assay. Data on the y-axis represent the percentage of values obtained for the untreated reference samples. All assays were performed in triplicate, and average values with standard errors are presented. The differences in cytotoxicity of HTCCs were not statistically significant.
       </p>
       <div class="sb-div caption-clear"/>
      </div>
     </div>
     <p id="p-12">Next, the dose-dependence was tested for the HTCCs. The inhibitory activity of selected polymers was verified for three different concentrations, and obtained data are shown in 
      <strong>
       <a id="xref-fig-2-1" class="xref-fig" href="#F2">Figure 2</a>
      </strong>.
     </p>
     <div id="F2" class="fig pos-float type-figure odd">
      <div class="highwire-figure">
       <div class="fig-inline-img-wrapper">
        <div class="fig-inline-img">
         <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F2.large.jpg?width=800&amp;;height=600&amp;;carousel=1" title="Dose-dependent inhibition of MERS-CoV and SARS-CoV-2 replication. Vero (MERS-CoV) or Vero E6 cells (SARS-CoV-2) were inoculated with a given virus in the presence of different concentrations of HTCC. Replication of viruses was evaluated at 48 h post-inoculation using RT-qPCR. The data are presented as Log Removal Value (LRV) compared to the untreated sample. The assay was performed in triplicate, and average values with standard errors are displayed." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1117103470" data-figure-caption="&lt;;div class=&quot;;highwire-markup&quot;;&gt;;&lt;;span xmlns=&quot;;http://www.w3.org/1999/xhtml&quot;; class=&quot;;caption-title&quot;;&gt;;Dose-dependent inhibition of MERS-CoV and SARS-CoV-2 replication.&lt;;/span&gt;; Vero (MERS-CoV) or Vero E6 cells (SARS-CoV-2) were inoculated with a given virus in the presence of different concentrations of HTCC. Replication of viruses was evaluated at 48 h post-inoculation using RT-qPCR. The data are presented as Log Removal Value (LRV) compared to the untreated sample. The assay was performed in triplicate, and average values with standard errors are displayed.&lt;;/div&gt;;" data-icon-position="" data-hide-link-title="0">
          <span class="hw-responsive-img">
           <img class="highwire-fragment fragment-image lazyload" alt="Figure 2." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F2.medium.gif" width="440" height="387"/>
           <noscript>
            <img class="highwire-fragment fragment-image" alt="Figure 2." src="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F2.medium.gif" width="440" height="387"/>
           </noscript>
          </span>
         </a>
        </div>
       </div>
       <ul class="highwire-figure-links inline">
        <li class="download-fig first">
         <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F2.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 2." data-icon-position="" data-hide-link-title="0">Download figure</a>
        </li>
        <li class="new-tab last">
         <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F2.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a>
        </li>
       </ul>
      </div>
      <div class="fig-caption">
       <span class="fig-label">Figure 2.</span>
       <span class="caption-title">Dose-dependent inhibition of MERS-CoV and SARS-CoV-2 replication.</span>
       <p id="p-13" class="first-child">Vero (MERS-CoV) or Vero E6 cells (SARS-CoV-2) were inoculated with a given virus in the presence of different concentrations of HTCC. Replication of viruses was evaluated at 48 h post-inoculation using RT-qPCR. The data are presented as Log Removal Value (LRV) compared to the untreated sample. The assay was performed in triplicate, and average values with standard errors are displayed.</p>
       <div class="sb-div caption-clear"/>
      </div>
     </div>
     <p id="p-14">Based on the data obtained, the basic parameters were calculated and are presented in 
      <strong>
       <a id="xref-table-wrap-1-1" class="xref-table" href="#T1">Table 1</a>
      </strong>.
     </p>
     <div id="T1" class="table pos-float">
      <div class="table-inline table-callout-links">
       <div class="callout">
        <span>View this table:</span>
        <ul class="callout-links">
         <li class="view-inline first">
          <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/1234186/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a>
         </li>
         <li class="view-popup">
          <a href="/highwire/markup/1234186/expansion?width=1000&amp;;height=500&amp;;iframe=true&amp;;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a>
         </li>
         <li class="download-ppt last">
          <a href="/highwire/powerpoint/1234186" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a>
         </li>
        </ul>
       </div>
      </div>
      <div class="table-caption">
       <span class="table-label">Table 1.</span>
       <p id="p-15" class="first-child">50% Cytotoxic concentration (CC
        <sub>50</sub>), 50% inhibitory concentration (IC
        <sub>50</sub>), and the selectivity index (SI) of two most effective HTCCs: HTCC-63 (for MERS-CoV) and HTCC-77 (for SARS-CoV-2).
       </p>
       <div class="sb-div caption-clear"/>
      </div>
     </div>
     <p id="p-16">The parameters observed for the SARS-CoV-2 appear to be favorable with SI above 12. It is also worth to note that HTCC was previously administered by inhalation in rats, and no adverse reactions were observed 
      <sup>
       <a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a>
      </sup>. In that study, HTCC was used as a carrier for the active substance, and as such, was reported to be promising for local sustained inhalation therapy of pulmonary diseases.
     </p>
    </div>
    <div id="sec-4" class="subsection">
     <h3>HTCCs hamper MERS-CoV and SARS-CoV-2 replication in human airway epithelium</h3>
     <p id="p-17">While the Vero cells constitute a convenient model for antiviral research, it is of utmost importance to verify whether the results obtained are not biased due to the artificial system used. This is especially important for compounds, which activity is based on electrostatic interaction. To verify whether the natural microenvironment, which is rich in sugars and charged molecules, does not abrogate the effectiveness of the inhibitors, we employed HAE cultures that mirror the fully differentiated layer linng the conductive airways, as well as the site of coronavirus replication. Briefly, fully differentiated HAE cultures were infected with a given virus 
      <sup>
       <a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">26</a>
      </sup> in the presence of previously selected HTCCs (200 μg/ml) or control PBS. Following inoculation, apical lavage samples were collected daily, and replication kinetics for each virus was investigated. The analysis revealed that the polymer efficiently hampered SARS-CoV-2 and MERS-CoV also in this model. For MERS-CoV, the inhibitory effect was the most evident at 72 h p.i., while for SARS-CoV-2 the most substantial decline of virus progeny was observed at 24 h p.i. (
      <strong>
       <a id="xref-fig-3-1" class="xref-fig" href="#F3">Figure 3</a>
      </strong>). Whether such kinetics will be reflected 
      <em>in vivo</em> it is to be investigated.
     </p>
     <div id="F3" class="fig pos-float type-figure odd">
      <div class="highwire-figure">
       <div class="fig-inline-img-wrapper">
        <div class="fig-inline-img">
         <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F3.large.jpg?width=800&amp;;height=600&amp;;carousel=1" title="Ex vivo inhibition of MERS-CoV and SARS-CoV-2 by HTCC in human airway epithelium cultures. HAE cultures were exposed to MERS-CoV or SARS-CoV-2 in the presence of HTCC-63 (for MERS-CoV) or HTCC-77 (for SARS-CoV-2) at 200 [[#x3BC]]g/ml or control PBS. To analyze virus replication kinetics, each day post infection, 100 [[#x3BC]]l of 1 [[#xD7]] PBS was applied to the apical surface of HAE cultures and collected after 10 min of incubation at 37[[#xB0]]C. Replication of viruses was evaluated using quantitative RT-qPCR. The data are presented as Log Removal Value (LRV) compared to the untreated sample. The assay was performed in triplicate, and average values with standard errors are shown." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1117103470" data-figure-caption="&lt;;div class=&quot;;highwire-markup&quot;;&gt;;&lt;;div xmlns=&quot;;http://www.w3.org/1999/xhtml&quot;;&gt;;&lt;;span class=&quot;;caption-title&quot;;&gt;;&lt;;em&gt;;Ex vivo&lt;;/em&gt;; inhibition of MERS-CoV and SARS-CoV-2 by HTCC in human airway epithelium cultures.&lt;;/span&gt;; HAE cultures were exposed to MERS-CoV or SARS-CoV-2 in the presence of HTCC-63 (for MERS-CoV) or HTCC-77 (for SARS-CoV-2) at 200 [[#x3BC]]g/ml or control PBS. To analyze virus replication kinetics, each day post infection, 100 [[#x3BC]]l of 1 [[#xD7]] PBS was applied to the apical surface of HAE cultures and collected after 10 min of incubation at 37[[#xB0]]C. Replication of viruses was evaluated using quantitative RT-qPCR. The data are presented as Log Removal Value (LRV) compared to the untreated sample. The assay was performed in triplicate, and average values with standard errors are shown.&lt;;/div&gt;;&lt;;/div&gt;;" data-icon-position="" data-hide-link-title="0">
          <span class="hw-responsive-img">
           <img class="highwire-fragment fragment-image lazyload" alt="Figure 3." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F3.medium.gif" width="440" height="392"/>
           <noscript>
            <img class="highwire-fragment fragment-image" alt="Figure 3." src="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F3.medium.gif" width="440" height="392"/>
           </noscript>
          </span>
         </a>
        </div>
       </div>
       <ul class="highwire-figure-links inline">
        <li class="download-fig first">
         <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F3.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 3." data-icon-position="" data-hide-link-title="0">Download figure</a>
        </li>
        <li class="new-tab last">
         <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F3.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a>
        </li>
       </ul>
      </div>
      <div class="fig-caption">
       <span class="fig-label">Figure 3.</span>
       <span class="caption-title">
        <em>Ex vivo</em> inhibition of MERS-CoV and SARS-CoV-2 by HTCC in human airway epithelium cultures.
       </span>
       <p id="p-18" class="first-child">HAE cultures were exposed to MERS-CoV or SARS-CoV-2 in the presence of HTCC-63 (for MERS-CoV) or HTCC-77 (for SARS-CoV-2) at 200 μg/ml or control PBS. To analyze virus replication kinetics, each day post infection, 100 μl of 1 × PBS was applied to the apical surface of HAE cultures and collected after 10 min of incubation at 37°C. Replication of viruses was evaluated using quantitative RT-qPCR. The data are presented as Log Removal Value (LRV) compared to the untreated sample. The assay was performed in triplicate, and average values with standard errors are shown.</p>
       <div class="sb-div caption-clear"/>
      </div>
     </div>
    </div>
    <div id="sec-5" class="subsection">
     <h3>HTCCs inhibits MERS-CoV and SARS-CoV-2 entry into susceptible cells</h3>
     <p id="p-19">Our previous research showed that the HTCC-mediated inhibition of coronaviral replication results from the electrostatic interaction between the polymer and the Spike protein of coronaviruses. We hypothesize that the selectivity of the inhibitors yields from the fitting charge distributions on the polymer and on the S proteins on the viral surface. While the interaction of a single charged moiety is relatively weak, the concatemeric nature of the virus and the polymer stabilizes the binding. Such structure-based interaction may be an interesting entry point for further fine-tuning of the polymeric inhibitors of viral replication.</p>
     <p id="p-20">To ensure that the observed effect was a result of coronavirus entry inhibition by HTCC, two experiments were performed. First, HAE cultures were inoculated with MERS-CoV in the presence of HTCC-63 (200 μg/ml) or control PBS and incubated for 2 h at 37°C. Next, cells were fixed, immunostained for MERS-CoV N protein and actin. Virus entry was analyzed with confocal microscopy. To visualize the effect, the signal attributed to intracellular MERS-CoV was quantified, and the results show that the internalization of MERS-CoV was drastically decreased (
      <strong>
       <a id="xref-fig-4-1" class="xref-fig" href="#F4">Figure 4A</a>
      </strong>).
     </p>
     <div id="F4" class="fig pos-float type-figure odd">
      <div class="highwire-figure">
       <div class="fig-inline-img-wrapper">
        <div class="fig-inline-img">
         <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F4.large.jpg?width=800&amp;;height=600&amp;;carousel=1" title="Coronavirus internalization into susceptible cells is hampered by HTCC. (A) Pre-cooled HAE cultures were incubated with ice-cold MERS-CoV suspension in the presence or absence of HTCC-63 (200 [[#x3BC]]g/ml) for 2 h at 37[[#xB0]]C. Next, cells were fixed in PFA and immunostained for MERS-CoV N protein and actin. Virus entry was analyzed with confocal microscopy. The data shown are representative of three independent experiments, each performed in triplicate. * P &lt;; 0.05. (B) A549 cells overexpressing ACE2 were incubated with lentiviral particles bearing GFP reporter gene, pseudotyped with SARS-CoV-2 Spike (S-SARS-CoV-2), VSV control G protein (VSV-G) or particles without an envelope protein ([[#x2206]]Env) in the presence of HTCC-77 or control PBS. After 2 h at 37[[#xB0]]C cells were washed with PBS and overlaid with fresh medium. Following 72 h incubation, GFP signal was measured using fluorometer and pseudovirus entry is presented as Relative Fluorescence Units per ml. The assay was performed in triplicate, and average values with standard errors are presented. ** P &lt;; 0.005." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1117103470" data-figure-caption="&lt;;div class=&quot;;highwire-markup&quot;;&gt;;&lt;;div xmlns=&quot;;http://www.w3.org/1999/xhtml&quot;;&gt;;&lt;;span class=&quot;;caption-title&quot;;&gt;;Coronavirus internalization into susceptible cells is hampered by HTCC.&lt;;/span&gt;; &lt;;strong&gt;;(A)&lt;;/strong&gt;; Pre-cooled HAE cultures were incubated with ice-cold MERS-CoV suspension in the presence or absence of HTCC-63 (200 [[#x3BC]]g/ml) for 2 h at 37[[#xB0]]C. Next, cells were fixed in PFA and immunostained for MERS-CoV N protein and actin. Virus entry was analyzed with confocal microscopy. The data shown are representative of three independent experiments, each performed in triplicate. * P &lt;; 0.05. (&lt;;strong&gt;;B&lt;;/strong&gt;;) A549 cells overexpressing ACE2 were incubated with lentiviral particles bearing GFP reporter gene, pseudotyped with SARS-CoV-2 Spike (S-SARS-CoV-2), VSV control G protein (VSV-G) or particles without an envelope protein ([[#x2206]]Env) in the presence of HTCC-77 or control PBS. After 2 h at 37[[#xB0]]C cells were washed with PBS and overlaid with fresh medium. Following 72 h incubation, GFP signal was measured using fluorometer and pseudovirus entry is presented as Relative Fluorescence Units per ml. The assay was performed in triplicate, and average values with standard errors are presented. ** P &lt;; 0.005.&lt;;/div&gt;;&lt;;/div&gt;;" data-icon-position="" data-hide-link-title="0">
          <span class="hw-responsive-img">
           <img class="highwire-fragment fragment-image lazyload" alt="Figure 4." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F4.medium.gif" width="440" height="162"/>
           <noscript>
            <img class="highwire-fragment fragment-image" alt="Figure 4." src="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F4.medium.gif" width="440" height="162"/>
           </noscript>
          </span>
         </a>
        </div>
       </div>
       <ul class="highwire-figure-links inline">
        <li class="download-fig first">
         <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F4.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 4." data-icon-position="" data-hide-link-title="0">Download figure</a>
        </li>
        <li class="new-tab last">
         <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F4.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a>
        </li>
       </ul>
      </div>
      <div class="fig-caption">
       <span class="fig-label">Figure 4.</span>
       <span class="caption-title">Coronavirus internalization into susceptible cells is hampered by HTCC.</span>
       <p id="p-21" class="first-child">
        <strong>(A)</strong> Pre-cooled HAE cultures were incubated with ice-cold MERS-CoV suspension in the presence or absence of HTCC-63 (200 μg/ml) for 2 h at 37°C. Next, cells were fixed in PFA and immunostained for MERS-CoV N protein and actin. Virus entry was analyzed with confocal microscopy. The data shown are representative of three independent experiments, each performed in triplicate. * P &lt;; 0.05. (
        <strong>B</strong>) A549 cells overexpressing ACE2 were incubated with lentiviral particles bearing GFP reporter gene, pseudotyped with SARS-CoV-2 Spike (S-SARS-CoV-2), VSV control G protein (VSV-G) or particles without an envelope protein (∆Env) in the presence of HTCC-77 or control PBS. After 2 h at 37°C cells were washed with PBS and overlaid with fresh medium. Following 72 h incubation, GFP signal was measured using fluorometer and pseudovirus entry is presented as Relative Fluorescence Units per ml. The assay was performed in triplicate, and average values with standard errors are presented. ** P &lt;; 0.005.
       </p>
       <div class="sb-div caption-clear"/>
      </div>
     </div>
     <p id="p-22">Due to the limited availability of tools for the SARS-CoV-2 we were not able to replicate the experiment for this virus. Here, we employed a surrogate system based on lentiviral vectors pseudotyped with full-length Spike protein of SARS-CoV-2. A549 cells overexpressing the ACE2 protein were incubated with pseudovirions harboring SARS-CoV-2 Spike or control VSV-G protein in the presence of HTCC-77 (100 μg/ml) or control PBS for 2 h at 37°C. After 72 h p.i. cells were lysed, and pseudovirus entry was quantified by measurement of the reporter GFP protein. The analysis showed a significant reduction in SARS-CoV-2 Spike pseudoviruses internalization in the presence of the polymer, while no inhibition was observed for the control VSV-G (
      <strong>
       <a id="xref-fig-4-2" class="xref-fig" href="#F4">Figure 4B</a>
      </strong>).
     </p>
     <p id="p-23">Next, to verify whether the mechanism of action for the highly pathogenic betacoronaviruses is similar to that observed for alphacoronaviruses 
      <sup>
       <a id="xref-ref-22-5" class="xref-bibr" href="#ref-22">22</a>
      </sup>, and is based on locking the interaction between the virus and the entry receptor, we analyzed MERS-CoV co-localization with its entry receptor, DPP4 in the presence or absence of the HTCC. For this, human cell line Huh7 was inoculated with the virus or mock in the presence of HTCC-63 (100 μg/ml) or control PBS and incubated for 2 h at 4°C. Subsequently, cells were fixed and immunostained for the DPP4 and MERS-CoV N using specific antibodies. Virus co-localization with its receptor was examined using confocal microscopy. Obtained results demonstrated that in the control samples, virions co-localize with the DPP4 protein, while in the presence of the polymer, this interaction is blocked (
      <strong>
       <a id="xref-fig-5-1" class="xref-fig" href="#F5">Figure 5</a>
      </strong>).
     </p>
     <div id="F5" class="fig pos-float type-figure odd">
      <div class="highwire-figure">
       <div class="fig-inline-img-wrapper">
        <div class="fig-inline-img">
         <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F5.large.jpg?width=800&amp;;height=600&amp;;carousel=1" title="HTCC blocks interaction between the virus and its entry receptor. Pre-cooled Huh7 cells were incubated for 3 h at 4[[#xB0]]C with ice-cold MERS-CoV or mock in the presence or absence of HTCC-63 (100 [[#x3BC]]g/ml). Next, cells were fixed with PFA and immunostained for MERS-CoV-N (green), DPP4 (red) and nuclear DNA (blue). MERS-CoV interaction with the DPP4 protein was analyzed with confocal microscopy. Co-localisation of DPP4 with MERS-CoV-N was determined by confocal microscopy and is presented as Manders[[#x2019]] M2 coefficient. The decrease in colocalization was statistically significant (P &lt;; 0.0005). Each image represents maximum projection of axial planes. Representative images are shown." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1117103470" data-figure-caption="&lt;;div class=&quot;;highwire-markup&quot;;&gt;;&lt;;span xmlns=&quot;;http://www.w3.org/1999/xhtml&quot;; class=&quot;;caption-title&quot;;&gt;;HTCC blocks interaction between the virus and its entry receptor.&lt;;/span&gt;; Pre-cooled Huh7 cells were incubated for 3 h at 4[[#xB0]]C with ice-cold MERS-CoV or mock in the presence or absence of HTCC-63 (100 [[#x3BC]]g/ml). Next, cells were fixed with PFA and immunostained for MERS-CoV-N (green), DPP4 (red) and nuclear DNA (blue). MERS-CoV interaction with the DPP4 protein was analyzed with confocal microscopy. Co-localisation of DPP4 with MERS-CoV-N was determined by confocal microscopy and is presented as Manders[[#x2019]] M2 coefficient. The decrease in colocalization was statistically significant (P &lt;; 0.0005). Each image represents maximum projection of axial planes. Representative images are shown.&lt;;/div&gt;;" data-icon-position="" data-hide-link-title="0">
          <span class="hw-responsive-img">
           <img class="highwire-fragment fragment-image lazyload" alt="Figure 5." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F5.medium.gif" width="440" height="440"/>
           <noscript>
            <img class="highwire-fragment fragment-image" alt="Figure 5." src="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F5.medium.gif" width="440" height="440"/>
           </noscript>
          </span>
         </a>
        </div>
       </div>
       <ul class="highwire-figure-links inline">
        <li class="download-fig first">
         <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F5.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 5." data-icon-position="" data-hide-link-title="0">Download figure</a>
        </li>
        <li class="new-tab last">
         <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/31/2020.03.29.014183/F5.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a>
        </li>
       </ul>
      </div>
      <div class="fig-caption">
       <span class="fig-label">Figure 5.</span>
       <span class="caption-title">HTCC blocks interaction between the virus and its entry receptor.</span>
       <p id="p-24" class="first-child">Pre-cooled Huh7 cells were incubated for 3 h at 4°C with ice-cold MERS-CoV or mock in the presence or absence of HTCC-63 (100 μg/ml). Next, cells were fixed with PFA and immunostained for MERS-CoV-N (green), DPP4 (red) and nuclear DNA (blue). MERS-CoV interaction with the DPP4 protein was analyzed with confocal microscopy. Co-localisation of DPP4 with MERS-CoV-N was determined by confocal microscopy and is presented as Manders’ M2 coefficient. The decrease in colocalization was statistically significant (P &lt;; 0.0005). Each image represents maximum projection of axial planes. Representative images are shown.</p>
       <div class="sb-div caption-clear"/>
      </div>
     </div>
     <p id="p-25">Taking together, we show here that the previously developed and described polymeric HTCC anticoronaviral compounds based on chitosan are able to efficiently inhibit infection with emerging coronaviruses. We believe that the HTCC can be fine-tuned to target any coronavirus, and this interaction is specific to viruses that belong to the 
      <em>Coronaviridae</em> family. One may speculate that the inhibition results from the concatemeric nature of the virus surface and the fact that the polymer with appropriate charge distribution can interact with multiple sites on this surface. While the interaction of the monomer is relatively weak, and no inhibition is observable for monomers, the sum of interactions stabilizes the binding and specific inhibition is observed. Considering that the extended chain length for the HTCC used is ~700 nm this scenario seems realistic 
      <sup>
       <a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">27</a>
      </sup>. If that would be true, HTCC would constitute a first structure-specific inhibitor of viral replication. The major disadvantage of the HTCC is that, at present, it is not registered for use in humans. However, previous experience with HTCC in different laboratories shows that it may be delivered topically to the lungs, it is not associated with toxicity, and it does not worsen the lung function 
      <sup>
       <a id="xref-ref-25-2" class="xref-bibr" href="#ref-25">25</a>
      </sup>. We believe that HTCC is a promising drug candidate that should be further studied, as it provides a ready-to-use solution for SARS-CoV-2 and future emerging coronaviruses.
     </p>
    </div>
   </div>
   <div class="section" id="sec-6">
    <h2 class="">MATERIALS AND METHODS</h2>
    <div id="sec-7" class="subsection">
     <h3>The active compound</h3>
     <p id="p-26">The HTCC was prepared in the same manner as previously described 
      <sup>
       <a id="xref-ref-22-6" class="xref-bibr" href="#ref-22">22</a>,
       <a id="xref-ref-23-2" class="xref-bibr" href="#ref-23">23</a>,
       <a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">28</a>
      </sup>.
     </p>
    </div>
    <div id="sec-8" class="subsection">
     <h3>Plasmid constructs</h3>
     <p id="p-27">The codon-optimised full-length SARS-CoV-2 S gene was designed and purchased from GeneArt (Thermo Fisher Scientific, Poland). The gene was cloned into pCAGGS vector sequence verified that was a gift from Xingchuan Huang. psPAX (Addgene plasmid # 12260) and pMD2G (Addgene plasmid # 12259) was a gift from Didier Trono. Lego-G2 vector (Addgene plasmid #25917) was a gift from Boris Fehs.</p>
    </div>
    <div id="sec-9" class="subsection">
     <h3>Cell culture</h3>
     <p id="p-28">Vero and Vero E6 (
      <em>Cercopithecus aethiops</em>; kidney epithelial; ATCC: CCL-81 and CRL-1586), Huh7 (
      <em>Homo sapiens</em>; hepatocellular carcinoma; ECACC: 01042712) and A549 cells with ACE2 overexpression (A549/ACE2)
      <sup>
       <a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">29</a>
      </sup> were cultured in Dulbecco’s MEM (Thermo Fisher Scientific, Poland) supplemented with 3% fetal bovine serum (heat-inactivated; Thermo Fisher Scientific, Poland) and antibiotics: penicillin (100 U/ml), streptomycin (100 μg/ml), and ciprofloxacin (5 μg/ml). Cells were maintained at 37°C under 5% CO
      <sub>2</sub>.
     </p>
    </div>
    <div id="sec-10" class="subsection">
     <h3>Human airway epithelium (HAE) cultures</h3>
     <p id="p-29">Human airway epithelial cells were isolated from conductive airways resected from transplant patients. The study was approved by the Bioethical Committee of the Medical University of Silesia in Katowice, Poland (approval no: KNW/0022/KB1/17/10 dated 16.02.2010). Written consent was obtained from all patients. Cells were dislodged by protease treatment, and later mechanically detached from the connective tissue. Further, cells were trypsinized and transferred onto permeable Transwell insert supports (ϕ = 6.5 mm). Cell differentiation was stimulated by the media additives and removal of media from the apical side after the cells reached confluence. Cells were cultured for 4-6 weeks to form well-differentiated, pseudostratified mucociliary epithelium. All experiments were performed in accordance with relevant guidelines and regulations.</p>
    </div>
    <div id="sec-11" class="subsection">
     <h3>Cell viability assay</h3>
     <p id="p-30">HAE cultures were prepared as described above. Cell viability assay was performed by using the XTT Cell Viability Assay (Biological Industries, Israel) according to the manufacturer’s instructions. On the day of the assay, 100 μl of the 1 × PBS with the 50 μl of the activated XTT solution was added to each well/culture insert. Following 2 h incubation at 37°C, the solution was transferred onto a 96-well plate, and the signal was measured at λ = 490 nm using the colorimeter (Spectra MAX 250, Molecular Devices). The obtained results were further normalized to the control sample, where cell viability was set to 100%.</p>
    </div>
    <div id="sec-12" class="subsection">
     <h3>Virus preparation and titration</h3>
     <p id="p-31">MERS-CoV stock (isolate England 1, 1409231v, National Collection of Pathogenic Viruses, Public Health England, United Kingdom) was generated by infecting monolayers of Vero cells. SARS-CoV-2 stock (isolate 026V-03883; kindly granted by Christian Drosten, Charité – Universitätsmedizin Berlin, Germany by the European Virus Archive - Global (EVAg); 
      <a href="https://www.european-virus-archive.com/">https://www.european-virus-archive.com/</a>) was generated by infecting monolayers of Vero E6 cells. The virus-containing liquid was collected at day 3 post-infection (p.i.), aliquoted and stored at −80°C. Control Vero or Vero E6 cell lysate from mock-infected cells was prepared in the same manner. Virus yield was assessed by titration on fully confluent Vero or Vero E6 cells in 96-well plates, according to the method of Reed and Muench. Plates were incubated at 37°C for 3 days and the cytopathic effect (CPE) was scored by observation under an inverted microscope.
     </p>
    </div>
    <div id="sec-13" class="subsection">
     <h3>Virus infection</h3>
     <p id="p-32">In 
      <em>in vitro</em> experiments, fully confluent Vero, Vero E6, or Huh7 cells in 96-well plates (TPP) were exposed to MERS-CoV, SARS-CoV-2 or mock at a TCID
      <sub>50</sub> of 400 per ml in the presence of tested polymer or control medium. Following a 2 h incubation at 37°C, unbound virions were removed by washing with 100 μl of 1 × PBS and fresh medium containing dissolved respective polymer was added to each well. Samples of cell culture supernatant were collected at day 3 p.i. and analyzed using RT-qPCR.
     </p>
     <p id="p-33">For the 
      <em>ex vivo</em> study, fully differentiated human airway epithelium (HAE) cultures were exposed to the tested polymer or control PBS for 30 min at 37°C, following inoculation with MERS-CoV or SARS-CoV-2 at a TCID
      <sub>50</sub> of 400 per ml in the presence of the polymer or control PBS. Following 2 h incubation at 37°C, unbound virions were removed by washing with 200 μl of 1 × PBS and HAE cultures were maintained at an air—liquid interphase for the rest of the experiment. To analyze virus replication kinetics, each day p.i., 100 μl of 1 × PBS was applied at the apical surface of HAE and collected following the 10 min incubation at 32°C. All samples were stored at −80°C and analyzed using RT-qPCR.
     </p>
    </div>
    <div id="sec-14" class="subsection">
     <h3>Isolation of nucleic acids and reverse transcription (RT)</h3>
     <p id="p-34">Viral DNA/RNA Kit (A&amp;;A Biotechnology, Poland) was used for nucleic acid isolation from cell culture supernatants, according to the manufacturer’s instructions. cDNA samples were prepared with a High Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific, Poland), according to the manufacturer’s instructions.</p>
    </div>
    <div id="sec-15" class="subsection">
     <h3>Quantitative PCR (qPCR)</h3>
     <p id="p-35">Viral RNA yield was assessed using real-time PCR (7500 Fast Real-Time PCR; Life Technologies, Poland). cDNA was amplified in a reaction mixture containing 1 × qPCR Master Mix (A&amp;;A Biotechnology, Poland), in the presence of probe (100 nM) and primers (450 nM each).</p>
     <div id="T2" class="table pos-float">
      <div class="table-inline table-callout-links">
       <div class="callout">
        <span>View this table:</span>
        <ul class="callout-links">
         <li class="view-inline first">
          <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/1234189/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a>
         </li>
         <li class="view-popup">
          <a href="/highwire/markup/1234189/expansion?width=1000&amp;;height=500&amp;;iframe=true&amp;;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a>
         </li>
         <li class="download-ppt last">
          <a href="/highwire/powerpoint/1234189" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a>
         </li>
        </ul>
       </div>
      </div>
      <div class="table-caption">
       <span class="table-label">Table 1.</span>
       <span class="caption-title">Primers and probes.</span>
       <div class="sb-div caption-clear"/>
      </div>
     </div>
     <p id="p-36">The reaction was carried out according to the scheme: 2 min at 50°C and 10 min at 92°C, followed by 40 cycles of 15 s at 92°C and 1 min at 60°C. In order to assess the copy number for N gene, DNA standards were prepared, as described before 
      <sup>
       <a id="xref-ref-26-2" class="xref-bibr" href="#ref-26">26</a>
      </sup>.
     </p>
    </div>
    <div id="sec-16" class="subsection">
     <h3>Immunostaining and confocal imaging</h3>
     <p id="p-37">Fixed cells were permeabilized with 0.1% Triton X-100 in 1 × PBS and incubated overnight at 4°C in 1× PBS supplemented with 5% bovine serum albumin (BSA) and 0.5% Tween 20. To visualize MERS-CoV particles, cells were incubated for 2 h at room temperature with mouse anti-MERS-CoV N IgGs (1:000 dilution, Sino Biological, China), followed by 1 h of incubation with Alexa Fluor 488-labeled goat anti-mouse IgG (2.5 µg/ml; Thermo Fisher Scientific, Poland). Actin filaments was stained using phalloidin coupled with Alexa Fluor 633 (0.2 U/ml; Thermo Fisher Scientific, Poland). Nuclear DNA was stained with DAPI (4’,6’-diamidino-2-phenylindole) (0.1 µg/ml; Sigma-Aldrich, Poland). Immunostained cultures were mounted on glass slides in ProLong Gold antifade medium (Thermo Fisher Scientific, Poland). Fluorescent images were acquired under a Leica TCS SP5 II confocal microscope (Leica Microsystems GmbH, Mannheim, Germany) and a Zeiss LSM 710 confocal microscope (Carl Zeiss Microscopy GmbH). Images were acquired using Leica Application Suite Advanced Fluorescence LAS AF v. 2.2.1 (Leica Microsystems CMS GmbH) or ZEN 2012 SP1 software (Carl Zeiss Microscopy GmbH) deconvolved with Huygens Essential package version 4.4 (Scientific Volume Imaging B.V., The Netherlands) and processed using ImageJ 1.47v (National Institutes of Health, Bethesda, MD, USA). At the time of the study, no antibodies specific to SARS-CoV-2 were available to us.</p>
    </div>
    <div id="sec-17" class="subsection">
     <h3>Pseudovirus production and transduction</h3>
     <p id="p-38">293T cells were seeded on 10 cm
      <sup>2</sup> dishes, cultured for 24 h at 37°C with 5% CO
      <sub>2</sub> and transfected using polyethyleneimine (Sigma-Aldrich, Poland) with the lentiviral packaging plasmid (psPAX), the VSV-G envelope plasmid (pMD2G) or SARS-CoV-2 S glycoprotein (pCAGGS-SARS-CoV-2-S) and third plasmid encoding GFP protein (Lego-G2). Cells were further cultured for 72 h at 37°C with 5% CO
      <sub>2</sub> and pseudoviruses were collected every 24 h and stored at 4°C.
     </p>
     <p id="p-39">A549/ACE2 cells were seeded in 48-wells plates, cultured for 24 h at 37°C with 5% CO
      <sub>2</sub> and transduced with pseudoviruses harboring VSV-G or S-SARS-CoV-2 proteins or lacking the fusion protein (∆Env) in the presence of polybrene (4 µg/ml; Sigma-Aldrich, Poland) and HTCC-77 (100 μg/ml) or control PBS. After 4 h incubation at 37°C unbound virions were removed by washing thrice with 1 × PBS and cells were further cultured for 72 h at 37°C with 5% CO
      <sub>2.</sub> Cells were lysed in RIPA buffer (50 mM Tris, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, pH 7.5) and transferred onto black 96-wells plates. Fluorescence levels were measured on a microplate reader Gemini EM (Molecular Devices, UK).
     </p>
    </div>
    <div id="sec-18" class="subsection">
     <h3>Statistical analysis</h3>
     <p id="p-40">All the experiments were performed in triplicate, and the results are presented as mean ± standard deviation (SD). To determine the significance of the obtained results Student t test was carried out. P values of &lt;; 0.05 were considered significant.</p>
    </div>
   </div>
   <div class="section" id="sec-19">
    <h2 class="">AUTHOR CONTRIBUTIONS STATEMENT</h2>
    <p id="p-44">A.M., Y.C., A.S., E. B. D., X.G., Y.G., J.L., L.C. conducted the experiments. M.O., M.U., and S.R.M provided materials and methods for the study. A.M., K.P. designed the study and experiments, analysed the data and wrote the manuscript. K.L., D.L., F.Z., M.N., K.S. analysed the data. K.P. supervised the study. All authors reviewed the manuscript and approved the submitted version. All authors agreed to be personally accountable for their own contributions and to ensure that questions related the accuracy or integrity of any part of the work are appropriately investigated, resolved, and the resolution documented in the literature.</p>
   </div>
   <div class="section" id="sec-20">
    <h2 class="">ADDITIONAL INFORMATION</h2>
    <div class="section COI-statement" id="sec-21">
     <h3>Competing interests</h3>
     <p id="p-45">The authors declare no competing financial interests.</p>
    </div>
   </div>
   <div class="section ack" id="ack-1">
    <h2 class="">ACKNOWLEDGEMENTS</h2>
    <p id="p-41">This work was supported by the subsidy from the Polish Ministry of Science and Higher Education for the research on the SARS-CoV-2 and a grant from the National Science Center UMO-2017/27/B/NZ6/02488 to KP.</p>
    <p id="p-42">The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.</p>
    <p id="p-43">The technology is owned by the 
     <strong>Jagiellonian University</strong> (Krakow, Poland) and protected by a patent no 
     <strong>WO2013172725A1</strong> and associated documents.
    </p>
   </div>
   <div class="section ref-list" id="ref-list-1">
    <h2 class="">REFERENCES</h2>
    <ol class="cit-list">
     <li>
      <a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1 in text" id="ref-1">↵</a>
      <div class="cit ref-cit ref-book" id="cit-2020.03.29.014183v1.1">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Fields</span>, 
          <span class="cit-name-given-names">B. N.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Knipe</span>, 
          <span class="cit-name-given-names">D. M.</span>
         </span> &amp;; 
         <span class="cit-auth">
          <span class="cit-name-surname">Howley</span>, 
          <span class="cit-name-given-names">P. M.</span>
         </span>
         <span class="cit-source">Fields virology</span>. 
         <span class="cit-edition">6th</span> edn, (
         <span class="cit-publ-name">Wolters Kluwer Health/Lippincott Williams &amp;; Wilkins</span>, 
         <span class="cit-pub-date">2013</span>).
        </cite>
       </div>
       <div class="cit-extra"/>
      </div>
     </li>
     <li>
      <div class="cit ref-cit ref-journal no-rev-xref" id="cit-2020.03.29.014183v1.2" data-doi="10.1056/NEJMra032498">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Peiris</span>, 
          <span class="cit-name-given-names">J. S.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Yuen</span>, 
          <span class="cit-name-given-names">K. Y.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Osterhaus</span>, 
          <span class="cit-name-given-names">A. D.</span>
         </span> &amp;; 
         <span class="cit-auth">
          <span class="cit-name-surname">Stöhr</span>, 
          <span class="cit-name-given-names">K.</span>
         </span>
         <span class="cit-article-title">The severe acute respiratory syndrome</span>. 
         <abbr class="cit-jnl-abbrev">N Engl J Med</abbr>
         <span class="cit-vol">349</span>, 
         <span class="cit-fpage">2431</span>–
         <span class="cit-lpage">2441</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1056/NEJMra032498</span> (
         <span class="cit-pub-date">2003</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.aulast%253DPeiris%26rft.auinit1%253DJ.%2BS.M.%26rft.volume%253D349%26rft.issue%253D25%26rft.spage%253D2431%26rft.epage%253D2441%26rft.atitle%253DThe%2BSevere%2BAcute%2BRespiratory%2BSyndrome%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMra032498%26rft_id%253Dinfo%253Apmid%252F14681510%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1056/NEJMra032498&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=14681510&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.29.014183.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
        <a href="/lookup/external-ref?access_num=000187326200011&amp;;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
         <span>Web of Science</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <div class="cit ref-cit ref-journal no-rev-xref" id="cit-2020.03.29.014183v1.3" data-doi="10.1128/JVI.01244-13">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">de Groot</span>, 
          <span class="cit-name-given-names">R. J.</span>
         </span>
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group</span>. 
         <abbr class="cit-jnl-abbrev">J Virol</abbr>
         <span class="cit-vol">87</span>, 
         <span class="cit-fpage">7790</span>–
         <span class="cit-lpage">7792</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1128/JVI.01244-13</span> (
         <span class="cit-pub-date">2013</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DJ%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.01244-13%26rft_id%253Dinfo%253Apmid%252F23678167%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjEwOiI4Ny8xNC83NzkwIjtzOjQ6ImF0b20iO3M6NDg6Ii9iaW9yeGl2L2Vhcmx5LzIwMjAvMDMvMzEvMjAyMC4wMy4yOS4wMTQxODMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink">
         <span>
          <span class="cit-reflinks-full-text">
           <span class="free-full-text">FREE </span>Full Text
          </span>
         </span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <div class="cit ref-cit ref-journal no-rev-xref" id="cit-2020.03.29.014183v1.4" data-doi="10.1056/NEJMoa1211721">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Zaki</span>, 
          <span class="cit-name-given-names">A. M.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">van Boheemen</span>, 
          <span class="cit-name-given-names">S.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Bestebroer</span>, 
          <span class="cit-name-given-names">T. M.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Osterhaus</span>, 
          <span class="cit-name-given-names">A. D.</span>
         </span> &amp;; 
         <span class="cit-auth">
          <span class="cit-name-surname">Fouchier</span>, 
          <span class="cit-name-given-names">R. A.</span>
         </span>
         <span class="cit-article-title">Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia</span>. 
         <abbr class="cit-jnl-abbrev">N Engl J Med</abbr>
         <span class="cit-vol">367</span>, 
         <span class="cit-fpage">1814</span>–
         <span class="cit-lpage">1820</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1056/NEJMoa1211721</span> (
         <span class="cit-pub-date">2012</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.aulast%253DZaki%26rft.auinit1%253DA.%2BM.%26rft.volume%253D367%26rft.issue%253D19%26rft.spage%253D1814%26rft.epage%253D1820%26rft.atitle%253DIsolation%2Bof%2Ba%2Bnovel%2Bcoronavirus%2Bfrom%2Ba%2Bman%2Bwith%2Bpneumonia%2Bin%2BSaudi%2BArabia.%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa1211721%26rft_id%253Dinfo%253Apmid%252F23075143%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1056/NEJMoa1211721&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=23075143&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.29.014183.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
        <a href="/lookup/external-ref?access_num=000310773200008&amp;;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
         <span>Web of Science</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <div class="cit ref-cit ref-journal no-rev-xref" id="cit-2020.03.29.014183v1.5" data-doi="10.1038/nm1024">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">van der Hoek</span>, 
          <span class="cit-name-given-names">L.</span>
         </span>
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Identification of a new human coronavirus</span>. 
         <abbr class="cit-jnl-abbrev">Nat Med</abbr>
         <span class="cit-vol">10</span>, 
         <span class="cit-fpage">368</span>–
         <span class="cit-lpage">373</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1038/nm1024</span> (
         <span class="cit-pub-date">2004</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DNature%2Bmedicine%26rft.stitle%253DNat%2BMed%26rft.aulast%253Dvan%2Bder%2BHoek%26rft.auinit1%253DL.%26rft.volume%253D10%26rft.issue%253D4%26rft.spage%253D368%26rft.epage%253D373%26rft.atitle%253DIdentification%2Bof%2Ba%2Bnew%2Bhuman%2Bcoronavirus.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnm1024%26rft_id%253Dinfo%253Apmid%252F15034574%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1038/nm1024&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=15034574&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.29.014183.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
        <a href="/lookup/external-ref?access_num=000220587000027&amp;;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
         <span>Web of Science</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <div class="cit ref-cit ref-journal no-rev-xref" id="cit-2020.03.29.014183v1.6" data-doi="10.1371/journal.pmed.0020240">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">van der Hoek</span>, 
          <span class="cit-name-given-names">L.</span>
         </span>
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Croup is associated with the novel coronavirus NL63</span>. 
         <abbr class="cit-jnl-abbrev">PLoS Med</abbr>
         <span class="cit-vol">2</span>, 
         <span class="cit-fpage">e240</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1371/journal.pmed.0020240</span> (
         <span class="cit-pub-date">2005</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.stitle%253DPLoS%2BMed%26rft.aulast%253Dvan%2Bder%2BHoek%26rft.auinit1%253DL.%26rft.volume%253D2%26rft.issue%253D8%26rft.spage%253De240%26rft.epage%253De240%26rft.atitle%253DCroup%2Bis%2Bassociated%2Bwith%2Bthe%2Bnovel%2Bcoronavirus%2BNL63.%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pmed.0020240%26rft_id%253Dinfo%253Apmid%252F16104827%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1371/journal.pmed.0020240&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=16104827&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.29.014183.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7 in text" id="ref-7">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.7" data-doi="10.1056/NEJMoa2001017">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Zhu</span>, 
          <span class="cit-name-given-names">N.</span>
         </span>
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">A Novel Coronavirus from Patients with Pneumonia in China, 2019</span>. 
         <abbr class="cit-jnl-abbrev">N Engl J Med</abbr>
         <span class="cit-vol">382</span>, 
         <span class="cit-fpage">727</span>–
         <span class="cit-lpage">733</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1056/NEJMoa2001017</span> (
         <span class="cit-pub-date">2020</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa2001017%26rft_id%253Dinfo%253Apmid%252F31978945%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1056/NEJMoa2001017&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=31978945&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.29.014183.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8 in text" id="ref-8">↵</a>
      <div class="cit ref-cit ref-web" id="cit-2020.03.29.014183v1.8">
       <div class="cit-metadata unstructured">&lt;;
        <a href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019">https://www.who.int/emergencies/diseases/novel-coronavirus-2019</a>&gt;; (
       </div>
       <div class="cit-extra"/>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9 in text" id="ref-9">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.9">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Andersen</span>, 
          <span class="cit-name-given-names">K. G.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Rambaut</span>, 
          <span class="cit-name-given-names">A.</span>
         </span> &amp;; 
         <span class="cit-auth">
          <span class="cit-name-surname">Lipkin</span>, 
          <span class="cit-name-given-names">W. I.</span>
         </span>
         <span class="cit-article-title">The proximal origin of SARS-CoV-2</span>. 
         <abbr class="cit-jnl-abbrev">Nature Medicine</abbr>, doi:
         <a href="https://doi.org/10.1038/s41591-020-0820-9">https://doi.org/10.1038/s41591-020-0820-9</a> (
         <span class="cit-pub-date">2020</span>).
        </cite>
       </div>
       <div class="cit-extra"/>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10 in text" id="ref-10">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.10" data-doi="10.1128/JVI.01498-14">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Corman</span>, 
          <span class="cit-name-given-names">V. M.</span>
         </span>
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat</span>. 
         <abbr class="cit-jnl-abbrev">J Virol</abbr>
         <span class="cit-vol">88</span>, 
         <span class="cit-fpage">11297</span>–
         <span class="cit-lpage">11303</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1128/JVI.01498-14</span> (
         <span class="cit-pub-date">2014</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DJ%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.01498-14%26rft_id%253Dinfo%253Apmid%252F25031349%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjExOiI4OC8xOS8xMTI5NyI7czo0OiJhdG9tIjtzOjQ4OiIvYmlvcnhpdi9lYXJseS8yMDIwLzAzLzMxLzIwMjAuMDMuMjkuMDE0MTgzLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink">
         <span>
          <span class="cit-reflinks-abstract">Abstract</span>
          <span class="cit-sep cit-reflinks-variant-name-sep">/</span>
          <span class="cit-reflinks-full-text">
           <span class="free-full-text">FREE </span>Full Text
          </span>
         </span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11 in text" id="ref-11">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.11" data-doi="10.1038/srep25049">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Zhang</span>, 
          <span class="cit-name-given-names">Z.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Shen</span>, 
          <span class="cit-name-given-names">L.</span>
         </span> &amp;; 
         <span class="cit-auth">
          <span class="cit-name-surname">Gu</span>, 
          <span class="cit-name-given-names">X.</span>
         </span>
         <span class="cit-article-title">Evolutionary Dynamics of MERS-CoV: Potential Recombination, Positive Selection and Transmission</span>. 
         <abbr class="cit-jnl-abbrev">Sci Rep</abbr>
         <span class="cit-vol">6</span>, 
         <span class="cit-fpage">25049</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1038/srep25049</span> (
         <span class="cit-pub-date">2016</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DSci%2BRep%26rft.volume%253D6%26rft.spage%253D25049%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fsrep25049%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1038/srep25049&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12 in text" id="ref-12">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.12" data-doi="10.1038/nature12328">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Lu</span>, 
          <span class="cit-name-given-names">G.</span>
         </span>
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26</span>. 
         <abbr class="cit-jnl-abbrev">Nature</abbr>
         <span class="cit-vol">500</span>, 
         <span class="cit-fpage">227</span>–
         <span class="cit-lpage">231</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1038/nature12328</span> (
         <span class="cit-pub-date">2013</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DNature%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnature12328%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1038/nature12328&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13 in text" id="ref-13">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.13" data-doi="10.1038/nature12005">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Raj</span>, 
          <span class="cit-name-given-names">V. S.</span>
         </span>
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC</span>. 
         <abbr class="cit-jnl-abbrev">Nature</abbr>
         <span class="cit-vol">495</span>, 
         <span class="cit-fpage">251</span>–
         <span class="cit-lpage">254</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1038/nature12005</span> (
         <span class="cit-pub-date">2013</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DNature%26rft.volume%253D495%26rft.spage%253D251%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnature12005%26rft_id%253Dinfo%253Apmid%252F23486063%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1038/nature12005&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=23486063&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.29.014183.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
        <a href="/lookup/external-ref?access_num=000316652300054&amp;;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
         <span>Web of Science</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14 in text" id="ref-14">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.14" data-doi="10.1186/s12985-015-0439-5">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Mackay</span>, 
          <span class="cit-name-given-names">I. M.</span>
         </span> &amp;; 
         <span class="cit-auth">
          <span class="cit-name-surname">Arden</span>, 
          <span class="cit-name-given-names">K. E.</span>
         </span>
         <span class="cit-article-title">MERS coronavirus: diagnostics, epidemiology and transmission</span>. 
         <abbr class="cit-jnl-abbrev">Virol J</abbr>
         <span class="cit-vol">12</span>, 
         <span class="cit-fpage">222</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1186/s12985-015-0439-5</span> (
         <span class="cit-pub-date">2015</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DVirol%2BJ%26rft.volume%253D12%26rft.spage%253D222%26rft_id%253Dinfo%253Adoi%252F10.1186%252Fs12985-015-0439-5%26rft_id%253Dinfo%253Apmid%252F26695637%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1186/s12985-015-0439-5&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=26695637&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.29.014183.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <div class="cit ref-cit ref-journal no-rev-xref" id="cit-2020.03.29.014183v1.15" data-doi="10.1111/2049-632X.12166">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Milne-Price</span>, 
          <span class="cit-name-given-names">S.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Miazgowicz</span>, 
          <span class="cit-name-given-names">K. L.</span>
         </span> &amp;; 
         <span class="cit-auth">
          <span class="cit-name-surname">Munster</span>, 
          <span class="cit-name-given-names">V. J.</span>
         </span>
         <span class="cit-article-title">The emergence of the Middle East respiratory syndrome coronavirus</span>. 
         <abbr class="cit-jnl-abbrev">Pathog Dis</abbr>
         <span class="cit-vol">71</span>, 
         <span class="cit-fpage">121</span>–
         <span class="cit-lpage">136</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1111/2049-632X.12166</span> (
         <span class="cit-pub-date">2014</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DPathog%2BDis%26rft_id%253Dinfo%253Adoi%252F10.1111%252F2049-632X.12166%26rft_id%253Dinfo%253Apmid%252F24585737%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1111/2049-632X.12166&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=24585737&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.29.014183.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16 in text" id="ref-16">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.16" data-doi="10.1016/S2213-2600(14)70158-4">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Chan</span>, 
          <span class="cit-name-given-names">R. W.</span>
         </span>
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study</span>. 
         <abbr class="cit-jnl-abbrev">Lancet Respir Med</abbr>
         <span class="cit-vol">2</span>, 
         <span class="cit-fpage">813</span>–
         <span class="cit-lpage">822</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1016/S2213-2600(14)70158-4</span> (
         <span class="cit-pub-date">2014</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DLancet%2BRespir%2BMed%26rft.volume%253D2%26rft.spage%253D813%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS2213-2600%252814%252970158-4%26rft_id%253Dinfo%253Apmid%252F25174549%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1016/S2213-2600(14)70158-4&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=25174549&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.29.014183.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17 in text" id="ref-17">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.17" data-doi="10.1128/mBio.00221-18">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Agostini</span>, 
          <span class="cit-name-given-names">M. L.</span>
         </span>
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease</span>. 
         <abbr class="cit-jnl-abbrev">mBio</abbr>
         <span class="cit-vol">9</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1128/mBio.00221-18</span> (
         <span class="cit-pub-date">2018</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DmBio%26rft_id%253Dinfo%253Adoi%252F10.1128%252FmBio.00221-18%26rft_id%253Dinfo%253Apmid%252F29511076%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoibWJpbyI7czo1OiJyZXNpZCI7czoxMzoiOS8yL2UwMDIyMS0xOCI7czo0OiJhdG9tIjtzOjQ4OiIvYmlvcnhpdi9lYXJseS8yMDIwLzAzLzMxLzIwMjAuMDMuMjkuMDE0MTgzLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink">
         <span>
          <span class="cit-reflinks-abstract">Abstract</span>
          <span class="cit-sep cit-reflinks-variant-name-sep">/</span>
          <span class="cit-reflinks-full-text">
           <span class="free-full-text">FREE </span>Full Text
          </span>
         </span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18 in text" id="ref-18">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.18" data-doi="10.1128/mBio.00047-14">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Agnihothram</span>, 
          <span class="cit-name-given-names">S.</span>
         </span>
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant</span>. 
         <abbr class="cit-jnl-abbrev">MBio</abbr>
         <span class="cit-vol">5</span>, 
         <span class="cit-fpage">e00047</span>–
         <span class="cit-lpage">00014</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1128/mBio.00047-14</span> (
         <span class="cit-pub-date">2014</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DMBio%26rft.volume%253D5%26rft.spage%253De00047%26rft_id%253Dinfo%253Adoi%252F10.1128%252FmBio.00047-14%26rft_id%253Dinfo%253Apmid%252F24667706%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1128/mBio.00047-14&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=24667706&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.29.014183.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19 in text" id="ref-19">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.19" data-doi="10.1073/pnas.0805240105">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Ratia</span>, 
          <span class="cit-name-given-names">K.</span>
         </span>
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication</span>. 
         <abbr class="cit-jnl-abbrev">Proc Natl Acad Sci U S A</abbr>
         <span class="cit-vol">105</span>, 
         <span class="cit-fpage">16119</span>–
         <span class="cit-lpage">16124</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1073/pnas.0805240105</span> (
         <span class="cit-pub-date">2008</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DProc%2BNatl%2BAcad%2BSci%2BU%2BS%2BA%26rft_id%253Dinfo%253Adoi%252F10.1073%252Fpnas.0805240105%26rft_id%253Dinfo%253Apmid%252F18852458%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMjoiMTA1LzQyLzE2MTE5IjtzOjQ6ImF0b20iO3M6NDg6Ii9iaW9yeGl2L2Vhcmx5LzIwMjAvMDMvMzEvMjAyMC4wMy4yOS4wMTQxODMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink">
         <span>
          <span class="cit-reflinks-abstract">Abstract</span>
          <span class="cit-sep cit-reflinks-variant-name-sep">/</span>
          <span class="cit-reflinks-full-text">
           <span class="free-full-text">FREE </span>Full Text
          </span>
         </span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20 in text" id="ref-20">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.20" data-doi="10.1016/j.antiviral.2006.03.001">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Barnard</span>, 
          <span class="cit-name-given-names">D. L.</span>
         </span>
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin</span>. 
         <abbr class="cit-jnl-abbrev">Antiviral Res</abbr>
         <span class="cit-vol">71</span>, 
         <span class="cit-fpage">53</span>–
         <span class="cit-lpage">63</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1016/j.antiviral.2006.03.001</span> (
         <span class="cit-pub-date">2006</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DAntiviral%2Bresearch%26rft.stitle%253DAntiviral%2BRes%26rft.aulast%253DBarnard%26rft.auinit1%253DD.%2BL.%26rft.volume%253D71%26rft.issue%253D1%26rft.spage%253D53%26rft.epage%253D63%26rft.atitle%253DEnhancement%2Bof%2Bthe%2Binfectivity%2Bof%2BSARS-CoV%2Bin%2BBALB%252Fc%2Bmice%2Bby%2BIMP%2Bdehydrogenase%2Binhibitors%252C%2Bincluding%2Bribavirin.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.antiviral.2006.03.001%26rft_id%253Dinfo%253Apmid%252F16621037%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1016/j.antiviral.2006.03.001&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=16621037&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F31%2F2020.03.29.014183.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
        <a href="/lookup/external-ref?access_num=000238904100007&amp;;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
         <span>Web of Science</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21 in text" id="ref-21">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.21" data-doi="10.1128/CMR.00023-07">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Cheng</span>, 
          <span class="cit-name-given-names">V. C.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Lau</span>, 
          <span class="cit-name-given-names">S. K.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Woo</span>, 
          <span class="cit-name-given-names">P. C.</span>
         </span> &amp;; 
         <span class="cit-auth">
          <span class="cit-name-surname">Yuen</span>, 
          <span class="cit-name-given-names">K. Y.</span>
         </span>
         <span class="cit-article-title">Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection</span>. 
         <abbr class="cit-jnl-abbrev">Clin Microbiol Rev</abbr>
         <span class="cit-vol">20</span>, 
         <span class="cit-fpage">660</span>–
         <span class="cit-lpage">694</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1128/CMR.00023-07</span> (
         <span class="cit-pub-date">2007</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DClinical%2BMicrobiology%2BReviews%26rft.stitle%253DClin.%2BMicrobiol.%2BRev.%26rft.aulast%253DCheng%26rft.auinit1%253DV.%2BC.%2BC.%26rft.volume%253D20%26rft.issue%253D4%26rft.spage%253D660%26rft.epage%253D694%26rft.atitle%253DSevere%2BAcute%2BRespiratory%2BSyndrome%2BCoronavirus%2Bas%2Ban%2BAgent%2Bof%2BEmerging%2Band%2BReemerging%2BInfection%26rft_id%253Dinfo%253Adoi%252F10.1128%252FCMR.00023-07%26rft_id%253Dinfo%253Apmid%252F17934078%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiY21yIjtzOjU6InJlc2lkIjtzOjg6IjIwLzQvNjYwIjtzOjQ6ImF0b20iO3M6NDg6Ii9iaW9yeGl2L2Vhcmx5LzIwMjAvMDMvMzEvMjAyMC4wMy4yOS4wMTQxODMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink">
         <span>
          <span class="cit-reflinks-abstract">Abstract</span>
          <span class="cit-sep cit-reflinks-variant-name-sep">/</span>
          <span class="cit-reflinks-full-text">
           <span class="free-full-text">FREE </span>Full Text
          </span>
         </span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22 in text" id="ref-22">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.22" data-doi="10.1371/journal.pone.0156552">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Milewska</span>, 
          <span class="cit-name-given-names">A.</span>
         </span>
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">HTCC: Broad Range Inhibitor of Coronavirus Entry</span>. 
         <abbr class="cit-jnl-abbrev">PLoS One</abbr>
         <span class="cit-vol">11</span>, 
         <span class="cit-fpage">e0156552</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1371/journal.pone.0156552</span> (
         <span class="cit-pub-date">2016</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DPLoS%2BOne%26rft.volume%253D11%26rft.spage%253De0156552%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0156552%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1371/journal.pone.0156552&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference 23 in text" id="ref-23">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.23" data-doi="10.1016/j.antiviral.2012.11.006">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Milewska</span>, 
          <span class="cit-name-given-names">A.</span>
         </span>
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Novel polymeric inhibitors of HCoV-NL63</span>. 
         <abbr class="cit-jnl-abbrev">Antiviral Res</abbr>
         <span class="cit-vol">97</span>, 
         <span class="cit-fpage">112</span>–
         <span class="cit-lpage">121</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1016/j.antiviral.2012.11.006</span> (
         <span class="cit-pub-date">2013</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DAntiviral%2BRes%26rft.volume%253D97%26rft.spage%253D112%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.antiviral.2012.11.006%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1016/j.antiviral.2012.11.006&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24 in text" id="ref-24">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.24">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Kamil</span>, 
          <span class="cit-name-given-names">K.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Aleksandra</span>, 
          <span class="cit-name-given-names">M.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Maria</span>, 
          <span class="cit-name-given-names">N.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Krzysztof</span>, 
          <span class="cit-name-given-names">P.</span>
         </span> &amp;; 
         <span class="cit-auth">
          <span class="cit-name-surname">Krzysztof</span>, 
          <span class="cit-name-given-names">S.</span>
         </span>
         <span class="cit-article-title">THE USE OF CHITOSAN POLYMER IN THE TREATMENT AND PREVENTION OF INFECTIONS CAUSED BY CORONAVIRUSES</span>.
        </cite>
       </div>
       <div class="cit-extra"/>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference 25 in text" id="ref-25">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.25" data-doi="10.1080/21691401.2018.1463231">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Yang</span>, 
          <span class="cit-name-given-names">T. T.</span>
         </span>
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Cyclosporine A/porous quaternized chitosan microspheres as a novel pulmonary drug delivery system</span>. 
         <abbr class="cit-jnl-abbrev">Artif Cells Nanomed Biotechnol</abbr>
         <span class="cit-vol">46</span>, 
         <span class="cit-fpage">552</span>–
         <span class="cit-lpage">564</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1080/21691401.2018.1463231</span> (
         <span class="cit-pub-date">2018</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DArtif%2BCells%2BNanomed%2BBiotechnol%26rft.volume%253D46%26rft.spage%253D552%26rft_id%253Dinfo%253Adoi%252F10.1080%252F21691401.2018.1463231%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1080/21691401.2018.1463231&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference 26 in text" id="ref-26">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.26">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth cit-collab">A, M.</span>
         <span class="cit-etal">et al.</span>
        </cite>
       </div>
       <div class="cit-extra"/>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference 27 in text" id="ref-27">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.27">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Kühtreiber</span>, 
          <span class="cit-name-given-names">W. M.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">P.</span>, 
          <span class="cit-name-given-names">L. R.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Chick</span>, 
          <span class="cit-name-given-names">W. L.</span>
         </span> &amp;; 
         <span class="cit-auth cit-collab">View ORCID Profil Anna Kula-Pacurar, J. W.</span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Agnieszka</span>
          <span class="cit-name-given-names">Suder</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Artur</span>
          <span class="cit-name-given-names">Szczepanski</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Agnieszka</span>
          <span class="cit-name-given-names">Dabrowska</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Katarzyna</span>
          <span class="cit-name-given-names">Owczarek</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Marek</span>
          <span class="cit-name-given-names">Ochman</span>
         </span>, 
         <span class="cit-article-title">Tomasz Stacel View ORCID Profile</span>. 
         <abbr class="cit-jnl-abbrev">Cell Encapsulation Technology and Therapeutics</abbr>. (
         <span class="cit-pub-date">1999</span>).
        </cite>
       </div>
       <div class="cit-extra"/>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference 28 in text" id="ref-28">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.28" data-doi="10.1016/j.msec.2017.03.047">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Ciejka</span>, 
          <span class="cit-name-given-names">J.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Wolski</span>, 
          <span class="cit-name-given-names">K.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Nowakowska</span>, 
          <span class="cit-name-given-names">M.</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Pyrc</span>, 
          <span class="cit-name-given-names">K.</span>
         </span> &amp;; 
         <span class="cit-auth">
          <span class="cit-name-surname">Szczubiałka</span>, 
          <span class="cit-name-given-names">K.</span>
         </span>
         <span class="cit-article-title">Biopolymeric nano/microspheres for selective and reversible adsorption of coronaviruses</span>. 
         <abbr class="cit-jnl-abbrev">Mater Sci Eng C Mater Biol Appl</abbr>
         <span class="cit-vol">76</span>, 
         <span class="cit-fpage">735</span>–
         <span class="cit-lpage">742</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1016/j.msec.2017.03.047</span> (
         <span class="cit-pub-date">2017</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DMater%2BSci%2BEng%2BC%2BMater%2BBiol%2BAppl%26rft.volume%253D76%26rft.spage%253D735%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.msec.2017.03.047%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1016/j.msec.2017.03.047&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference 29 in text" id="ref-29">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.29.014183v1.29" data-doi="10.1128/JVI.02078-14">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Milewska</span>, 
          <span class="cit-name-given-names">A.</span>
         </span>
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells</span>. 
         <abbr class="cit-jnl-abbrev">J Virol</abbr>
         <span class="cit-vol">88</span>, 
         <span class="cit-fpage">13221</span>–
         <span class="cit-lpage">13230</span>
         <span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1128/JVI.02078-14</span> (
         <span class="cit-pub-date">2014</span>).
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DJ%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.02078-14%26rft_id%253Dinfo%253Apmid%252F25187545%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjExOiI4OC8yMi8xMzIyMSI7czo0OiJhdG9tIjtzOjQ4OiIvYmlvcnhpdi9lYXJseS8yMDIwLzAzLzMxLzIwMjAuMDMuMjkuMDE0MTgzLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink">
         <span>
          <span class="cit-reflinks-abstract">Abstract</span>
          <span class="cit-sep cit-reflinks-variant-name-sep">/</span>
          <span class="cit-reflinks-full-text">
           <span class="free-full-text">FREE </span>Full Text
          </span>
         </span>
        </a>
       </div>
      </div>
     </li>
    </ol>
   </div>
   <span class="highwire-journal-article-marker-end"/>
  </div>
 </body>
</html>
